Figure 2. Structures of 1ꢀ7.
Figure 1. HPLC profiles of the EtOAc extracts of C. mollipilium
cultivated with (a) nicotinamide 100 μM and (b) control as
detected by UV absorption at 215 nm.
C. mollipilium was cultivated in a YM liquid medium
with100 μM nicotinamide for 16daysat25°C (Supporting
Information). The culture medium (13 L) was extracted
twice with ethyl acetate. The ethyl acetate extract (1.4 g)
was separated by Sephadex LH-20, silica gel column chro-
matography, and reversed-phase HPLC to afford diverse
C13-polyketides, mollipilin A (1, 17.3 mg), B (2, 13.7 mg),
C (3, 5.7 mg), D (4, 5.5 mg), E (5, 2.7 mg), F (6, 14.6 mg),
and (ꢀ)-aureonitol (7, 488 mg) (Figure 2).
fungi and successfully isolated numerous novel natural
products containing unprecedented carbon skeletal com-
pounds, including tenuipyrone and indigotides CꢀE.6
Although NADþ-dependent HDACs have been identi-
fied in a number of fungi7 and are involved in the formation
and spreading of heterochromatin for transcriptional silenc-
ing,8 a study of their effects on secondary metabolite pro-
duction in fungi has yet to be reported. We hypothesized
that the addition of a NADþ-dependent HDAC inhibitor in
a fungal culture medium would realize transcriptional up-
regulation of biosynthetic gene clusters and enhance the
production of fungal secondary metabolites. Consequently,
we applied three typical inhibitors (nicotinamide, sirtinol,
and splitomycin)9 to our natural product study and found
that Chaetomium mollipilium cultivated with nicotinamide
(100 μM) showed a notable change in the secondary meta-
bolites (Figure 1). Five new C13-polyketides, mollipilin AꢀE
(1ꢀ5), as well as known spiroketal 6 (named as mollipilin
F) and (ꢀ)-aureonitol (7) were isolated. Herein we discuss
the structures of 1ꢀ5 and the absolute stereochemistry of
6 as well as their plausible biosynthetic relationship and
cell growth inhibitory activity.
The HREIMS of mollipilin A (1) at m/z 236.1049 [M]þ
(calcd: m/z 236.1049) suggested that the molecular formula
was C13H16O4, which required six degrees of unsaturation.
The IR spectrum (3445, 1698, and 1674 cmꢀ1) indicated
the presence of a hydroxy group and two R,β-unsaturated
carbonyl groups. The 13C NMR and DEPT spectra showed
the presence of one keto carbonyl, one aldehyde, one
quaternary sp2 carbon, five tertiary sp2 carbons, two oxy-
methines, one oxymethylene, one methylene, and one methyl
1
group (Table S1). The H and 13C NMR and HMQC
spectra indicated the presence of an epoxide function based
on resonance signals at δC 50.4 (C-11) and 49.4 (C-12) and
δH 3.40 (ddd, J = 7.3, 5.0, 2.2 Hz, H-11), 3.06 (dd, J = 5.5,
5.0 Hz, Ha-12), and 2.69 (dd, J = 5.5, 2.2 Hz, Hb-12). The
1
1Hꢀ H COSY spectrum exhibited sequential correlations
from H3-1 to H-5 and H-9 to H2-12, while the HMBC
correlations from H-9 and H-10 to C-8 carbonyl implied the
presence of a 9-en-8-one function (Figure 3). In addition, the
long-range correlations of H-4/C-6, H-5/C-13, and H-7/C-
6, C-8 suggested C-5ꢀC-6ꢀC-13 and C-6ꢀC-7ꢀC-8 link-
ages (Figure 3), and the large coupling constants of H-3/
H-4 (15.6 Hz) and H-9/H-10 (15.8 Hz) indicated that C-3/
C-4 and C-9/C-10 olefins had trans geometries (Table S1).
The 5E configuration from the NOE of H-5/H-13 con-
firmed the planar structure of 1 (Figure 3).
The 1H and 13C NMR spectra of mollipilin B (2),
C13H18O4 [HREIMS: m/z 238.1194 [M]þ (calcd: m/z
238.1205)], agreed well with those of 1, except 2 had two
additional methylene signals and lacked the signals as-
signed to the C-9/C-10 trans-olefin in 1 (Table S1). These
observations suggested that the C-9/C-10 double bond in 1
was reduced to methylenes in 2, which was consistent with
the strong IR band at 1718 cmꢀ1 due to a saturated
(5) (a) Williams, R. B.; Henrikson, J. C.; Hoover, A. R.; Lee, A. E.;
Cichewicz, R. H. Org. Biomol. Chem. 2008, 7, 1895–1897. (b) Henrikson,
J. C.; Hoover, A. R.; Joyner, P. M.; Cichewicz, R. H. Org. Biomol. Chem.
2009, 7, 435–438.
(6) (a) Asai, T.; Yamamoto, T.; Oshima, Y. Tetrahedron Lett. 2011,
52, 7042–7045. (b) Asai, T.; Dan, L.; Obara, Y.; Taniguchi, T.; Monde,
K.; Yamashita, K.; Oshima, Y. Tetrahedron Lett. 2012, 53, 2239–2243.
(c) Asai, T.; Chung, Y. M.; Sakurai, H.; Ozeki, T.; Chang, F. R.;
Yamashita, K.; Oshima, Y. Org. Lett. 2012, 54, 513–515. (d) Asai, T.;
Yamamoto, T.; Oshima, Y. Org. Lett. 2012, 54, 2006–2009.
(7) (a) Graessle, S.; Dangl, M.; Haas, H.; Mair, K.; Trojer, P.;
Brandtner, E. M.; Walton, J. D.; Loidl, P.; Brosch, G. Biochim. Biophys.
Acta 2000, 1492, 120–126. (b) Trojer, P.; Brandtner, E. M.; Brosch, G.;
Loidl, P.; Galehr, J.; Linzmaier, R.; Haas, H.; Mair, K.; Tribus, M.;
Graessle, S. Nucleic Acids Res. 2003, 31, 3971–3981.
(8) Denu, J. M. Curr. Opin. Chem. Biol. 2005, 9, 431–440.
(9) HPLC analyses of the extracts obtained from the fungal culture
broths using sirtinol or splitomycin showed that no extract had distinct
enhancement of the secondary metabolite production. Moreover, it
showed that major constituents in the extracts were degradation and
hydroxylation products of sirtinol or splitomycin, suggesting that the
two inhibitors were unstable in the culture media of fungi. Therefore, the
two inhibitors seemed to be unsuitable for the experiments.
Org. Lett., Vol. 14, No. 21, 2012
5457